CRT 2017 : FDA Town Hall - Evaluating DES for High-Risk DAPT Patients

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

FDA Town Hall - Evaluating DES for High-Risk DAPT Patients

Featuring

  • Michael John
  • Davide Capodanno
  • Hans-Peter Stoll

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Adjunctive DAPT Labeling for DES – An FDA View - Michael John
Short versus Long DAPT Studies – An Academic View - Davide Capodanno
Study Designs of Short DAPT in the USA – Challenges and Execution of Pivotal Trials - Hans-Peter Stoll

Target Audience

Learning Objectives

Related Moments

Simple Education Interventional Cardiology: Coronary Physiology Course (iFR, FFR, CFR, CT-FFR), March 2017, London
Course
2 day course fromMarch 6-7th 2017 London, W2 2EA
Supported By
Sleep-disordered Breathing in Heart Failure – Current State of the Art
Journal
Aricle on Sleep-disordered Breathing in Heart Failure – Current State of the Art
The Brugada Syndrome – Diagnosis, Clinical Implications and Risk Stratification
Journal
Article on The Brugada Syndrome – Diagnosis, Clinical Implications and Risk Stratification
Loading Simple Education